in vivo male flinders sensitive line (fsl) rats and male cd1 mice, exposed to model genetic and environmentally induced depression, respectively, were injected intraperitoneally with alcar 100 mg/kg for 21 days
This happens to almost everyone taking GLP-1 medicines, as the body adjusts to the weight loss and learns to use energy more efficiently
Injectable treatments will continue to play a huge role, particularly for people already established on treatment, people who prefer weekly dosing, and those using higher-dose options to maximise weight loss results
The SURMOUNT-1 study, a phase III clinical trial published in The New England Journal of Medicine , indicated that Tirzepatide effectively reduced body weight in individuals with obesity
Novo Nordisks semaglutide is expected to lose its patent protection in Canada, Brazil, India, and China in 20252026
The monthly fee covers virtual evaluations, prescription coordination when appropriate, medication delivery, provider monitoring, and ongoing support